AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

MHC- and TCR-binding residues of myelin glycoprotein peptide characterized.

Vaccine Weekly

| April 07, 2004 | COPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2004 APR 7 - (NewsRx.com & NewsRx.net) -- Scientists have characterized the MHC- and TCR-binding residues of the myelin oligodendrocyte glycoprotein 38-51 peptide.

"Myelin oligodendrocyte glycoprotein (MOG) is a major experimental autoimmune encephalomyelitis (EAE) antigen in H-2[superscript]b mice and a potential autoantigen in multiple sclerosis. How well MOG peptides bind to MHC and how TCR recognize the peptide/MHC complex have important implications for thymic selection as well as T cell activation in the periphery. In this study, we have characterized amino acids in the MOG[subscript]38-51 peptide important for peptide binding to I-A[superscript]b, and for TCR recognition of the peptide/MHC complex," researchers in New Zealand and the United States report.

"We found that the amino acids R41, F44, R46 and V47 constituted the major TCR contact residues, as alanine substitution at these positions abrogated T cell responses without decreasing their binding affinity to I-A[superscript]b," stated Troels R. Petersen and collaborators at the Malaghan Institute of Medical Research in New Zealand and Harvard University and the La Jolla Institute for Allergy and Immunology in the U.S. "In addition, G38 and W39 were found to be minor TCR contact residues. Finally, substituting tyrosine for alanine at position 40 decreased binding to ...

Related articles from newspapers, magazines, journals, and more
Research from Malaghan Institute of Medical Research in the area of allergies...
Newspaper article from: Biotech Week September 10, 2008 700+ words
...and colleagues, Malaghan Institute of Medical Research...N. van Panhuys, Malaghan Institute of Medical Research...South, Wellington, New Zealand. The publisher of...Denmark. Keywords: New Zealand, Wellington, Allergies...
RESEARCHERS TO WORK ON NEW ARTHRITIS TREATMENT.
News wire article from: Asia Africa Intelligence Wire February 22, 2005 700+ words
(From New Zealand Press Association) Wellington, Feb 22 - New Zealand's Malaghan Institute is working to discover...for arthritis. The Malaghan Institute is an independent...pharmaceutical potential of New Zealand's flora and fauna...
Immunity's memories, lost and found: discovery of peripheral effector T cells...
Magazine article from: The Scientist Roberts, Josh P. August 25, 2003 700+ words
...basically." The results were "visually stunning," says Graham Le Gros, director of research for New Zealand's Malaghan Institute. Lefrancois' group took the other route to their findings, grinding samples from different tissues...
AUSTRALIA'S NOVOGEN REPORTS PROMISING RESULTS FOR CANCER DRUG.(Financial report)
News wire article from: AsiaPulse News May 2, 2007 700+ words
...cancer - which is often resistant to standard chemotherapy drugs. Research headed by Dr Michael Berridge of New Zealand's Malaghan Institute of Medical Research has found that phenoxodiol successfully targeted cancer proteins, inducing the cancerous...
MHC- and TCR-binding residues of myelin glycoprotein peptide characterized.
Newspaper article from: Pain & Central Nervous System Week April 5, 2004 700+ words
...researchers in New Zealand and the United...collaborators at the Malaghan Institute of Medical Research in New Zealand and Harvard University...Thomas Backstrom, Malaghan Institute of Medical Research...Wellington, New Zealand. E-mail: tbackstrom...
New Research Results Show That Investigational Drug Phenoxodiol Targets Cancer...
Press release article from: PR Newswire May 1, 2007 700+ words
...Professor Michael Berridge Ph.D., at the Malaghan Institute of Medical Research - New Zealand's leading medical research facility focused...from the study, to be presented at the New Zealand Society of Oncology meeting to be held...
Biomedical science degree opens doors.
News wire article from: Asia Africa Intelligence Wire October 14, 2003 700+ words
...while it is common overseas, it is unique in New Zealand, providing a link between learning the fundamentals...science has been highlighted by the decision by Malaghan Institute of Medical Research, New Zealand's internationally recognised private biomedical...
Medical unit will move to university.
News wire article from: Asia Africa Intelligence Wire August 26, 2003 700+ words
...research institute has quit Wellington School of Medicine and will move to Victoria University. Malaghan Institute of Medical Research -- New Zealand's internationally recognised biomedical research centre -- is set to move from Wellington...
Behind The Headlines: Sitting at a desk can give you DVT.(Deep Venous...
Magazine article from: GP Liddle, Rachel May 19, 2006 700+ words
...computer screen. The term eThrombosis was first coined in 2003 by Richard Beasley, from the Malaghan Institute of Medical Research in New Zealand. He reported the case of a 32-year-old man who lost consciousness a few weeks after developing...
TO THE POINT.
News wire article from: Asia Africa Intelligence Wire March 28, 2005 700+ words
...if Comalco quits New Zealand (March 17). But...of Asians entering New Zealand ? J HIBBS, Upper...figure raised for the Malaghan Institute on Lollipop Day was...diseases. G LE GROS, Malaghan Institute It's easy to work...
For more facts and information, see all results

Source: HighBeam Research, MHC- and TCR-binding residues of myelin glycoprotein peptide...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA